Feed Item (AI Text)
Title: Sen-Jam's COVID Therapeutic Receives Final Approval from NHRC to Commence their Clinical Trial in Partnership with Duke University School of Medicine | Sen-Jam Pharmaceutical
Canonical URL: https://wefunder.com/feed/152893
Published at: 2022-02-20 16:31:43 UTC
Updated at: 2025-07-09 03:21:33 UTC

Content summary:
This past Friday at 5:19am, Sen-Jam Pharmaceutical in partnership with Duke University School of Medicine received full approval from the Nepal Health Research Committee to begin dosing for (SJP-oo2C); a promising COVID-19 therapeutic embarking on...

Key claims:
- Title: Sen-Jam's COVID Therapeutic Receives Final Approval from NHRC to Commence their Clinical Trial in Partnership with Duke University School of Medicine | Sen-Jam Pharmaceutical | citation: https://wefunder.com/feed/152893#claim-feed-item-title
- Published at: 2022-02-20 16:31:43 UTC | citation: https://wefunder.com/feed/152893#claim-feed-item-published-at

Author: Jim Iversen
Subject: Sen-Jam Pharmaceutical
Entity ID: wefunder:feed_item:152893